Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 13.986\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCCOC(=O)Nc1nc(-c2ccc(C)cc2)c(C)s1
b.) N#CCCCSc1nnc(CSc2nc3ccccc3s2)n1-c1ccccc1
c.) N#Cc1c(SCc2c(Cl)cccc2Cl)nc(N)[nH]c1=S
Answer: a. CCCOC(=O)Nc1nc(-c2ccc(C)cc2)c(C)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOC(=O)Nc1nc(-c2ccc(C)cc2)c(C)s1
CCCOC(=O)Nc1nc(-c2ccc(C)cc2)c(C)s1
propyl N-[5-methyl-4-(4-methylphenyl)-1,3-thiazol-2-yl]carbamate